CDK2 inhibition produces a persistent population of polyploid cancer cells
Liliya Tyutyunyk-Massey1, Zibo Chen1, Xiuxia Liu1
1Molecular Pharmacology Program and.
Abstract:
Aneuploidy, a cancer hallmark, drives chromosomal instability, drug resistance, and clinically aggressive tumors. Cyclin-dependent kinase 2 (CDK2) antagonism with independent inhibitors or CDK2 knockdown triggered anaphase catastrophe. This disrupts supernumerary centrosome clustering, causing multipolar division and apoptosis. Time-lapse fluorescence microscopy of fluorescent ubiquitination-based cell cycle indicator (FUCCI) cell cycle probes transduced into aneuploid lung cancer cells revealed distinct fates of bipolar and polyploid cells after CDK2 inhibition. Apoptosis occurred in multipolar progeny but was repressed in persistent polyploid cancer cells. RNA-Seq analyses after CDK2 inhibition of 4N versus 2N lung cancer cells were enriched for CDK1 pathway and KIF family members. The Cancer Genome Atlas (TCGA) analysis of lung cancers indicated that CDK1 and KIF family member overexpression was associated with an unfavorable survival. Intravital microscopy of transplanted lung cancer cells in mice extended findings from the in vitro to in vivo settings. CDK2 inhibition of tumor-bearing mice produced polyploid cancer cells in vivo. These cancer cells were resistant to apoptosis and proliferated despite CDK2 inhibition. In contrast, polyploid populations were rarely detected in CDK2-inhibited human alveolar epithelial cells. These findings are translationally relevant. Combined targeting of CDK2 with CDK1 or kinesin family member antagonists should eliminate polyploid cancer cells, promote apoptosis, and augment antineoplastic effects.
Insights
Targeting cyclin-dependent kinase 2 (CDK2) causes cancer cell death, but some polyploid cells survive. Combined CDK2 and CDK1 or kinesin inhibition may eliminate resistant cancer cells.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Aneuploidy is a hallmark of cancer, contributing to chromosomal instability, drug resistance, and aggressive tumor progression.
- Cyclin-dependent kinase 2 (CDK2) plays a critical role in cell cycle regulation and is implicated in cancer development.
Purpose of the Study:
- To investigate the effects of CDK2 inhibition on aneuploid cancer cells and identify mechanisms of resistance.
- To explore potential therapeutic strategies for overcoming resistance to CDK2 inhibition in lung cancer.
Main Methods:
- Utilized time-lapse fluorescence microscopy with FUCCI probes to observe cell division dynamics in aneuploid lung cancer cells after CDK2 inhibition.
- Performed RNA-Seq analysis to identify molecular pathways affected by CDK2 inhibition in different ploidy states.
- Analyzed The Cancer Genome Atlas (TCGA) data to correlate CDK1 and KIF family member expression with patient survival.
- Employed intravital microscopy to validate in vitro findings in a mouse model of lung cancer.
Main Results:
- CDK2 inhibition induced anaphase catastrophe and apoptosis in aneuploid cells with supernumerary centrosomes.
- A subset of polyploid cancer cells survived CDK2 inhibition, exhibiting resistance to apoptosis and continued proliferation.
- RNA-Seq and TCGA analyses revealed enrichment of CDK1 and KIF pathways, with their overexpression linked to poor survival in lung cancer.
- In vivo studies confirmed the emergence of apoptosis-resistant polyploid cancer cells following CDK2 inhibition in mice.
Conclusions:
- CDK2 inhibition can trigger cell death in aneuploid cancer cells but leads to the selection of resistant polyploid populations.
- Combined targeting of CDK2 with CDK1 or kinesin family members presents a promising therapeutic strategy to eliminate resistant polyploid cancer cells.
- These findings have translational relevance for developing novel anti-cancer treatments for aggressive lung cancers.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Positive Regulator Molecules


